Internal Medicine

Arrhythmias

The Heart's Electrical Storm

Cardiovascular Disease

Now we're exploring arrhythmias, disorders of the heart's electrical system that can range from harmless palpitations to life-threatening emergencies. Think of the heart's conduction system as an intricate electrical grid; when this system malfunctions, the heart's rhythm becomes disrupted. I'll guide you through the mechanisms, classification, diagnosis, and management of these fascinating but complex conditions. Understanding arrhythmias is essential as they affect millions and require both acute intervention and long-term management strategies. Let's decode the heart's electrical language!

🩺 Basic Cardiac Electrophysiology Review

Before diving into arrhythmias, let's quickly review the normal cardiac conduction system and action potentials - this foundation is crucial for understanding what goes wrong in arrhythmias.

Conduction Pathway

  • SA node: Primary pacemaker (60-100 bpm)
  • AV node: Gatekeeper, delays impulse
  • Bundle of His: Connects atria to ventricles
  • Purkinje fibers: Rapid ventricular activation

Action Potential Types

  • Phase 4: Spontaneous depolarization (pacemaker cells)
  • Phase 0: Rapid depolarization (fast Na+ channels)
  • Phases 1-3: Repolarization (K+ efflux)
  • Refractory periods: Absolute and relative
Cell Type Automaticity Conduction Velocity Action Potential Duration
SA Node High (primary pacemaker) Slow (0.05 m/s) Short
Atrial Muscle None Fast (1 m/s) Medium
AV Node Moderate (40-60 bpm) Very slow (0.05 m/s) Medium
Ventricular Muscle None Fast (1 m/s) Long
Purkinje Fibers Low (20-40 bpm) Very fast (4 m/s) Long
Clinical Pearl: Remember the "backup pacemaker" hierarchy: SA node fails β†’ AV node takes over (40-60 bpm) β†’ if AV node fails, ventricular pacemakers take over (20-40 bpm).

πŸ”„ Mechanisms of Arrhythmogenesis

Arrhythmias develop through three primary mechanisms: abnormalities in impulse formation, abnormalities in impulse conduction, or combinations of both.

Enhanced Automaticity

  • Increased phase 4 depolarization
  • Ectopic pacemaker activity
  • Causes: catecholamines, ischemia, electrolyte abnormalities
  • Examples: sinus tachycardia, atrial tachycardia

Triggered Activity

  • Afterdepolarizations (early/delayed)
  • Occurs during/after repolarization
  • Causes: drugs (digoxin), long QT, ischemia
  • Examples: torsades de pointes, digoxin toxicity

Reentry Circuits

  • Most common mechanism
  • Requires: two pathways, unidirectional block, slow conduction
  • Causes: scar tissue, accessory pathways
  • Examples: AVNRT, atrial flutter, VT
Tutor Tip: Think of reentry like a circular racetrack with a roadblock - the impulse can't go forward through the blocked path, so it goes around the long way and re-enters from behind, creating a continuous loop.

πŸ“Š Classification of Arrhythmias

Arrhythmias are classified based on their origin (supraventricular vs ventricular), rate (bradycardia vs tachycardia), and regularity.

Major Arrhythmia Categories

Category Rate Origin Common Examples Clinical Significance
Bradyarrhythmias <60 bpm SA node, AV node Sinus bradycardia, heart block May cause syncope, fatigue
Supraventricular Tachycardias >100 bpm Above bundle of His AFib, AFL, AVNRT, AVRT Palpitations, rarely immediately life-threatening
Ventricular Tachycardias >100 bpm Ventricles VT, VF, torsades Potentially life-threatening, can degrade to VF
Conduction Disorders Variable Conduction system Bundle branch blocks, heart blocks May progress to complete heart block

Narrow Complex Tachycardias (QRS <120 ms)

  • Sinus tachycardia: Normal response
  • Atrial fibrillation: Irregularly irregular
  • Atrial flutter: Sawtooth pattern
  • AVNRT/AVRT: Regular, abrupt onset/termination

Wide Complex Tachycardias (QRS >120 ms)

  • Ventricular tachycardia: Regular, AV dissociation
  • SVT with aberrancy: Supraventricular origin
  • Pre-excited AF: WPW with AF, can be fatal
  • Paced rhythm: Pacemaker spikes
Important: Always assume a wide complex tachycardia is ventricular tachycardia until proven otherwise, especially in patients with structural heart disease.

πŸ‘¨β€βš•οΈ Common Arrhythmias: Clinical Features

Different arrhythmias present with characteristic symptoms, ECG findings, and clinical implications. Recognition is key to appropriate management.

Key Arrhythmia Profiles

Arrhythmia ECG Features Symptoms Acute Management Long-term Management
Atrial Fibrillation Irregularly irregular, no P waves Palpitations, dyspnea, fatigue Rate control, cardioversion if unstable Anticoagulation, rhythm control
Atrial Flutter Sawtooth flutter waves, regular ventricular response Palpitations, similar to AFib Rate control, cardioversion Anticoagulation, ablation
AVNRT Regular, narrow complex, P waves buried in QRS Palpitations, neck pounding, anxiety Vagal maneuvers, adenosine Ablation, medications
Ventricular Tachycardia Wide QRS, AV dissociation, rate >100 Palpitations, syncope, chest pain Cardioversion/defibrillation, amiodarone ICD, antiarrhythmics, ablation
Complete Heart Block AV dissociation, atrial rate > ventricular rate Syncope, fatigue, heart failure Atropine, temporary pacing Permanent pacemaker
Unstable Arrhythmia: Any arrhythmia with hypotension, altered mental status, ischemic chest pain, acute heart failure, or shock requires immediate electrical cardioversion/defibrillation. Don't delay for medications!

πŸ” Diagnostic Approach

Diagnosing arrhythmias requires capturing the abnormal rhythm, identifying underlying causes, and assessing hemodynamic consequences.

Diagnostic Tools

Test Indication Advantages Limitations
12-lead ECG Initial evaluation, acute symptoms Immediate, identifies ischemia, morphology Brief snapshot, may miss paroxysmal arrhythmias
Holter Monitor Frequent symptoms (daily) 24-48 hour continuous recording Limited duration, may miss infrequent events
Event Monitor Intermittent symptoms (weekly-monthly) Worn for 30 days, patient-activated Requires patient to trigger during symptoms
Implantable Loop Recorder Infrequent symptoms, unexplained syncope Monitors for 2-3 years, automatic detection Invasive, cost
Electrophysiology Study Risk stratification, guide ablation Precise diagnosis, can treat during procedure Invasive, procedural risks
Important: Always look for reversible causes of arrhythmias: electrolyte abnormalities (K+, Mg2+), ischemia, drug toxicity (digoxin, QT-prolonging drugs), thyroid dysfunction, pulmonary embolism.

πŸ’Š Management Strategies

Arrhythmia management involves acute termination of unstable rhythms, chronic prevention of recurrences, and reducing thromboembolic risk in atrial arrhythmias.

Antiarrhythmic Medications (Vaughan Williams Classification)

Class Mechanism Examples Main Uses Key Side Effects
Class I (Na+ channel blockers) Slow conduction Flecainide, Propafenone AFib, SVT (no structural heart disease) Proarrhythmia, negative inotropy
Class II (Beta-blockers) Reduce automaticity, slow AV conduction Metoprolol, Atenolol Rate control in AFib, sinus tachycardia Bradycardia, fatigue, bronchospasm
Class III (K+ channel blockers) Prolong repolarization Amiodarone, Sotalol AFib, VT, life-threatening arrhythmias QT prolongation, organ toxicity (amiodarone)
Class IV (Ca2+ channel blockers) Slow AV node conduction Verapamil, Diltiazem Rate control in AFib, AVNRT Hypotension, constipation, heart failure
Other Various mechanisms Digoxin, Adenosine Rate control (digoxin), acute SVT (adenosine) Narrow therapeutic window (digoxin)

Non-Pharmacological Therapies

Device Therapy

  • Pacemakers: For bradyarrhythmias
  • ICD: For VT/VF prevention
  • CRT: For dyssynchrony in heart failure

Ablation Therapy

  • Catheter ablation: For SVT, VT, AFib
  • Surgical ablation: Maze procedure for AFib
  • AV node ablation: With pacemaker for rate control
Treatment Goal: For atrial fibrillation, focus on the ABC pathway: A - Anticoagulation/Avoid stroke, B - Better symptom control, C - Cardiovascular risk factor management.

⚠️ Life-Threatening Arrhythmias

Some arrhythmias require immediate recognition and treatment to prevent sudden cardiac death.

Ventricular Fibrillation

  • Chaotic, disorganized ventricular activity
  • No cardiac output, immediate CPR required
  • Treatment: Immediate defibrillation
  • Prognosis: Fatal without treatment

Pulseless VT

  • Organized wide complex tachycardia
  • No palpable pulses, unconscious
  • Treatment: Immediate defibrillation
  • Prognosis: Poor without rapid intervention
Clinical Insight: Torsades de pointes is a polymorphic VT associated with long QT interval. Treatment includes magnesium sulfate and removing the cause of QT prolongation. Defibrillate if pulseless.

🧠 Key Takeaways

  • Arrhythmias result from disorders of impulse formation or conduction
  • Three main mechanisms: enhanced automaticity, triggered activity, reentry
  • Classify by rate (brady vs tachy), origin (supraventricular vs ventricular), QRS width
  • ECG is the primary diagnostic tool, supplemented by monitoring
  • Management depends on stability: unstable requires immediate cardioversion
  • Antiarrhythmic drugs are classified by mechanism (Vaughan Williams)
  • Non-pharmacologic options include devices (pacemakers, ICDs) and ablation
  • Always search for and treat reversible causes

🧭 Conclusion

We've navigated the complex electrical landscape of the heart, studentβ€”from the basic physiology of conduction to the dramatic presentations of life-threatening arrhythmias. Remember that arrhythmia management requires both acute intervention skills and long-term strategic thinking. I encourage you to master ECG interpretation and understand when arrhythmias become emergencies. Excellent work completing the cardiovascular section! Next, we'll move to respiratory diseases, starting with asthma and COPD.

In arrhythmias, the first question is always: "Is the patient stable?" This determines everything that follows.